Picosecond 532 nm Laser: An Optimal Device for the Reduction of Acquired Agminated Nevi.
agminated nevus
picosecond 532 nm laser
pigmented lesion
Journal
Lasers in surgery and medicine
ISSN: 1096-9101
Titre abrégé: Lasers Surg Med
Pays: United States
ID NLM: 8007168
Informations de publication
Date de publication:
29 Sep 2024
29 Sep 2024
Historique:
revised:
31
08
2024
received:
10
07
2024
accepted:
16
09
2024
medline:
30
9
2024
pubmed:
30
9
2024
entrez:
30
9
2024
Statut:
aheadofprint
Résumé
Agminated nevi are rare, grouped lesions, which are confined to one anatomic area. Herein, we report a case of successful cosmetic treatment of bilateral, acquired agminated nevi with a picosecond 532 nm Nd:YAG laser device. Literature search was completed on acquired agminated nevi. A healthy 21-year-old woman presented with numerous, grouped 1-mm brown-to-dark brown macules in the axillae bilaterally. Biopsies revealed lentiginous junctional nevi with mild atypia, leading to the diagnosis of agminated nevi. She was referred for laser treatment to improve cosmetic appearance. Two different laser devices were utilized initially, a picosecond 532 nm Nd:YAG laser on the left axilla and a millisecond domain 532 nm laser on the right. Greater improvement was noted with the picosecond 532 nm device. Three additional treatments were completed with the picosecond laser with significant improvement in pigmentation of melanocytic nevi. Various pigmented and melanocytic lesions have been noted to occur in an agminated pattern although their pathway of development remains unknown. While various devices have demonstrated efficacy for pigmented lesions, treatment of agminated nevi specifically is less reported or established. Our patient's presentation is novel because of the axillary location and bilateral distribution of multiple acquired agminated nevi, neither of which have been previously reported in the literature. We also report successful treatment utilizing a picosecond 532 nm laser. While laser can help improve the cosmetic appearance of pigmented lesions, most lasers do not remove all melanocytes, highlighting the need for close monitoring, as atypia and melanoma have been reported to develop in acquired agminated nevi. Thus, we present a case of acquired agminated nevi in a novel bilateral distribution in a healthy female successfully treated with a picosecond 532 nm laser.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Y. J. Choi, H. S. Kim, J. Y. Lee, H. O. Kim, and Y. M. Park, “Agminated Acquired Melanocytic Nevi of the Common and Dysplastic Type,” Annals of Dermatology 25, no. 3 (August 2013): 380–382.
Y. Shimasaki, Y. Fukuta, Y. Yoshida, H. Higaki‐Mori, and O. Yamamoto, “Acquired Agminated Melanocytic Naevi: Report of Two Cases and Review of the Literature,” Acta Dermato Venereologica 92, no. 6 (November 2012): 603–604.
J. W. Bragg, L. Swindle, A. C. Halpern, and A. A. Marghoob, “Agminated Acquired Melanocytic Nevi of the Common and Dysplastic Type,” Journal of the American Academy of Dermatology 52, no. 1 (January 2005): 67–73.
A. A. Marghoob, R. Blum, R. Nossa, K. J. Busam, D. Sachs, and A. Halpern, “Agminated Atypical (Dysplastic) Nevi: Case Report and Review of the Literature,” Archives of Dermatology 137, no. 7 (July 2001): 917–920.
J. Shin and Y. C. Kim, “Multiple Agminated Acquired Melanocytic Nevi,” Annals of Dermatology 25, no. 2 (May 2013): 251–252.
A. Agulló, B. Hinds, R. Santesteban, J. M. Mitxelena, and I. Yanguas, “Agminated Melanocytic Nevus Status Post Dabrafenib Therapy for Metastatic Melanoma,” Dermatology Online Journal 22, no. 7 (2016): 13030/qt9bx595cz.
T. Makino, Y. Matsui, R. Torai, M. Mizawa, and T. Shimizu, “Agminated Flexural Melanocytic Nevus Associated With Langerhans Cell Histiocytosis,” Journal of Dermatology 47, no. 7 (July 2020): e275–e276.
C. Surinach, P. Bahadoran, P. Vabres, et al., “Flexural Agminated Eruptive Nevi in Langerhans Cell Histiocytosis,” JAMA Dermatology 149, no. 5 (May 2013): 635–637.
H. Arora, L. Falto‐Aizpurua, A. Chacon, R. D. Griffith, and K. Nouri, “Lasers for Nevi: A Review,” Lasers in Medical Science 30, no. 7 (September 2015): 1991–2001.
O. Köse, “Carbon Dioxide Ablative Laser Treatment of Acquired Junctional Melanocytic Nevi,” Journal of Cosmetic Dermatology 20, no. 2 (February 2021): 491–496.
D. Duke, H. R. Byers, A. J. Sober, R. R. Anderson, and J. M. Grevelink, “Treatment of Benign and Atypical Nevi With the Normal‐Mode Ruby Laser and the Q‐Switched Ruby Laser: Clinical Improvement but Failure to Completely Eliminate Nevomelanocytes,” Archives of Dermatology 135, no. 3 (1999): 290–296.
M. Corradin, M. Alaibac, and A. Fortina, “A Case of Malignant Melanoma Arising From an Acquired Agminated Melanocytic Naevus,” Acta Dermato‐Venereologica 87, no. 5 (2007): 432–433.
M. C. Zipser, J. Mangana, P. A. Oberholzer, L. E. French, and R. Dummer, “Melanoma after Laser Therapy of Pigmented Lesions—Circumstances and Outcome,” European Journal of Dermatology 20, no. 3 (May‐June 2010): 334–338.
L. Curry, N. Cunningham, and S. Dhawan, “Cosmetic Light Therapies and the Risks of Atypical Pigmented Lesions,” Canadian Family Physician 67, no. 6 (June 2021): 433–435, https://doi.org/10.46747/cfp.6706433.
S. Delker, E. Livingstone, T. Schimming, D. Schadendorf, and K. G. Griewank, “Melanoma Diagnosed in Lesions Previously Treated by Laser Therapy,” Journal of Dermatology 44, no. 1 (January 2017): 23–28, https://doi.org/10.1111/1346-8138.13484.